EdmundABermudezMDMPH
Cardiology • North Venice, FLEchocardiography, Interventional Cardiology, Nuclear Cardiology, Peripheral Endovascular Interventional Cardiology
Interventional Cardiology First Physiciams Group
Dr. Bermudez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Healthcare Way
Suite 103
North Venice, FL 34275Phone+1 941-261-0160
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1998 - 2002
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1998
Michigan State University College of Human MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2007 - 2027
MI State Medical License 2006 - 2027
MA State Medical License 1998 - 2025
TN State Medical License 2007 - 2009
MN State Medical License 1996 - 2000
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Sarasota Magazine: Top Doctors Castle Connolly, 2011-2022
- CMS Meaningful Use Stage 1 Certification SRS EHR, SRSsoft, 2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 17 citations2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on ...Gregory J. Dehmer, Vinay Badhwar, Edmund A. Bermudez, Joseph C. Cleveland, Mauricio G. Cohen
Circulation. Cardiovascular Quality and Outcomes. 2020-03-23 - Regurgitant lesions of the aortic and mitral valves: considerations in determining the ideal timing of surgical intervention.Edmund A. Bermudez, William H. Gaasch
Heart Failure Clinics. 2006-10-01 - 206 citationsAspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.Nan Chiang, Edmund A. Bermudez, Paul M. Ridker, Shelley Hurwitz, Charles N. Serhan
Proceedings of the National Academy of Sciences of the United States of America. 2004-10-19
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
